Q2 EBITDA of SEK 173m Sawn wood and Pellets above Outlook: weaker, lower sawn wood prices Q2 EBITDA ...
Q2’22 somewhat below expectations H2’22 financials expected to improve Overall, a neutral to slightl...
Raute has now largely cleaned its Russian exposure and Western orders are materializing at a good pa...
Despite robust growth shown in Q2, Vaisala’s EBIT was a bit softer driven by increased cost pressure...
Q2 report due Thursday, 18 August Margins to improve 220bp y-o-y FVR of SEK 27-37 reiterated Final ...
Aftermarket drives organic recovery and 40% margins FX offsets slower organic ramp-up; EBIT up 2-0% ...
Delayed deliveries in Q2 but record-high order book Sales -1-2% and higher opex cut EBIT by 9-37% Sh...
ARR crossed SEK 10m in Q2, up 44% y-o-y Ests: slightly lower sales ‘22e, higher product dev.
Redeye states that the Q2 report came in somewhat below estimates but that the underlying developmen...
Redeye slightly lowers its Base Case and continues seeing meaningful upside from current trading.
Redeye raises its Base Case following Hoylu’s Q2’22 report.
Redeye retains its positive view on ADDvise following a solid Q2 report, with a strong contribution ...
Redeye comments on Xbrane Biopharma’s Q2 2022 report, which despite the recent setback, leaves us fe...
SRV reported surprisingly good Q2 profitability, but headwinds still remain.
Q2 sales -7% vs cons and EBIT SEK -8m vs cons 9m The higher activity remains, H2 sales to be better ...
Redeye retains its positive view on ADDvise following a Q2 report showing slightly better adjusted E...
Q2 EBIT SEK 219n vs. ABGSCe SEK 159m Deliveries 6% above, realized prices 10% above Webcast today at...
Raute’s Q2 revenue and EBIT were clearly worse than we expected, however order intake was well above...
Consti's net sales in Q2 amounted to EUR 73.1m, in line with our and consensus estimates (EUR 74.
